3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
35
Neoplasm Metastasis
7
Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Triple Negative Breast Neoplasms
4
Thyroid Neoplasms
4
Thyroid Cancer, Papillary
3
Sarcoma
3
Pancreatic Neoplasms
3
Neoplasms by Site
3
Melanoma
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Renal Cell
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Thyroid Diseases
2
Thoracic Neoplasms
2
Stomach Neoplasms
2
Salivary Gland Neoplasms
2
Respiratory Tract Neoplasms
2
Respiratory Tract Diseases
2
Ovarian Neoplasms
2
Multiple Endocrine Neoplasia Type 1
2
Lung Diseases
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Endocrine System Diseases
2
Interventions
ribociclib
1
Tamoxifen
1
Letrozole
1
Goserelin
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Advanced Metastatic Breast Cancer
×
Breast
×
Clear all
NCT02278120
2024-03-12
MONALEESA-7
Novartis
Phase 3
Completed
672 enrolled
16 charts
1 FDA